Business Context and Reporting Period
This Form 8-K Current Report was filed by Skye Bioscience, Inc. (formerly Emerald Bioscience, Inc.) on January 19, 2021. The report documents the effective date of a corporate name change and the associated update to the company's stock trading symbol.
Financial Metrics
This filing is a corporate governance and other events report. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
- Corporate Name: The company changed its name from Emerald Bioscience, Inc. to Skye Bioscience, Inc., effective January 19, 2021, following an amendment to its Articles of Incorporation approved on November 13, 2020.
- Stock Symbol: FINRA assigned the new stock symbol "SKYE," which became effective at the open of business on January 19, 2021.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, or contingencies. It strictly reports the administrative completion of the name and symbol change.
Key Facts for Investor Verification
- Verify the new ticker symbol "SKYE" is active on the relevant exchange.
- Confirm the legal name change to Skye Bioscience, Inc. is reflected in corporate registries.
- Note that this filing does not include financial performance data; refer to the most recent 10-K or 10-Q for financial status.